R APID M ICRO M ETHODS PPAR 2013 Jeffrey W. Weber, PAT Project Manager Kalamazoo, MI Oct 2013.

Slides:



Advertisements
Similar presentations
Enhancing Scientific Cooperation between the European Union and Central America Funded by the European Commission's Directorate-General for Research -
Advertisements

Why does PAT need Rapid Microbiology Methods? S.Lonardi, P.J.Newby, D.Ribeiro, B.Johnson PAT Subcommittee meeting October 23, 2002.
Rapid Microbiology Methods A Regulatory Viewpoint Bryan S. Riley, Ph.D. U.S. Food and Drug Administration Center for Drug Evaluation and Research Office.
SELECTING AND MANAGING CONTRACT STERILIZERS AND TESTING LABORATORIES
Environmental Health XIV. Standards and Monitoring Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental.
Astrix Technology Group Extending The LIMS To Benefit External Stakeholder Groups Robert D. Walla Presented At Pittcon 2006 Orlando, FL.
Reducing Costs & Achieving Superior Plant Energy Performance Real-time Information & Best Practices in Energy Management Presented by Shiva Subramanya.
Sterilized, Validated, Documented and Pyrogen Tested Wipers
Robust and affordable process control technologies for improving standards and optimising industrial operations Pau Puigdollers Project Coordinator.
By: Muhammad Naeem Quality Assurance and Regulatory Manager
Ray Scherzer FDA ACPS October 26, 2005 Breaking with Tradition: The Manufacturing Challenges Ahead!
Introduction The main objective of the HACCP system is to provide a high degree (close to 100%) of assurance that a food ready to be consumed will be.
May 14, 2014; BOLOGNA The role of the Green Economy in promoting a new model of Development and Green Business Danilo Čeh, Project ZERO WASTE PRO ORGANISATION:
LIFE SCIENCES Pharmaceutical Manufacturing Chemical & Biosciences Technology QA/QC in Pharmaceutical Industry Applied Biology & Chemistry.
Technical Report on Alternative Methods for Mycoplasma Testing Status update- Sept 2008 Kurt Brorson, Ph.D. CDER/FDA.
Personnel Basic Principles of GMP Workshop on
WHO FOOD COURSE SAFE FOOD PRODUCTION: HACCP HACCP and food regulators.
Xcellerex … speeding medicines to people … PAT for Biologics Ensuring Quality of Biologically Produced Drugs FDA Advisory Committee on Pharmaceutical Sciences.
ISPE/MESA Seminar Merck Sharp & Dohme Biologics Ireland Delivering value from MES: Optimizing Manufacturing Efficiency Paul Murray MES.
Quality By Design - A Generic Industry Perspective
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
EFSA MANAGEMENT PLAN 2008 The Management Plan
Organizational Gaps in Reaching the “Desired State” Helen Winkle.
Business Analysis: A Business Unit Perspective International Institute of Business Analysis January 18, 2012.
HYGIENE CONTROL IN THE BREWING INDUSTRY WITH REFERENCE TO AIR SAMPLING FOR BACTERIA AND PARTICLE CONTROL Environmental monitoring in the Food and Beverage.
QUALITY CONTROL MICROBIOLOGY
Water for Pharmaceutical Use Part 2: Water purification engineering
Environmental Management Systems A Postal Service Strategy May 16, 2006 Environmental Management Systems A Postal Service Strategy May 16, 2006 CHARLES.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
Wetland Monitoring What Do We Need? Integration of Wetland Monitoring and Wetland Management Wetlands and Waterways Program Maryland Dept. of the Environment.
1 PAT and Biological Products Tom Layloff FDA-SGE Management Sciences for Health The views expressed here are those of the author and not necessarily.
 Siemens Nederland N.V FDA13April Presented by Troy Logan at the Advisory Committee for Pharmaceutical Science meeting on April 13, 2004.
Raw Material Variability Raw Material CQAs Global Supply Chain PPAR 2011.
Important informations
Basics of Contamination Control
Why Participate in the WLA? Utility Perspective Preparation Emergency Response Plan Resources.
Basic Principles of GMP
10/11/ ENGINEERING RESEARCH CENTER FOR S TRUCTURED O RGANIC P ARTICULATE S YSTEMS RUTGERS UNIVERSITY PURDUE UNIVERSITY NEW JERSEY INSTITUTE OF TECHNOLOGY.
20 Oct 2004www.Torbeck.Org1 Impact of PAT on the Use of Statistics Lynn Torbeck
Molecule-to-Market-Place Quality
Moderated By Eyal Rivlin Lev Hakongressim, Weizmann Science Park, Ness Ziona May 2008.
FDA PROCESS ANALYTICAL TECHNOLOGY SUB COMMITTEE MEETING 25 TH FEBRUARY 2002 PERSPECTIVE ON PROCESS AND ANALYTICAL VALIDATION Robert S Chisholm.
Food Science and Industry
Continuous Processing and the Role of PAT PPAR 2011.
Multidisciplinary nature of Environmental Science Prepared by- Nitasha Sharma Clinical Instructor ACN.
Radiopharmaceutical Production
FDA’s Advisory Committee for Pharmaceutical Science The Subcommittee on Process Analytical Technologies (PAT): Closing Remarks Ajaz S. Hussain, Ph.D. Deputy.
IMT’s Food QA/QC Assays Andy Moreno Vice President, Microbiology Sales Engineering Cell: FAX:
FDA PAT Sub-Committee of Advisory Committee for Pharmaceutical Sciences June 12-13, 2002; Gaithersburg, MD Regulatory Challenges: Post-Approval PAT Applications.
Wyeth-Ayerst Pharmaceuticals1 CLEANING VALIDATION Microbial Monitoring Anthony M. Cundell Ph. D. Associate Director, QA Microbiological Development & Statistics.
Imon Rahman. Introduction During the early days of the pharmaceutical industry it was noticed that some solutions when injected into the bloodstream induced.
USP: Water for Pharmaceutical Purposes NCSLI – Metrological Traceability in Pure Water Testing August 22, 2011 Antonio Hernandez-Cardoso Senior Scientific.
PHARMACEUTICAL CLEANING: A RESEARCH AND METHODOLY APPROACH Adeyinka Aina 1#, Chris Edlin 1 and Charles Gordon 2 1. Pharmaceutical Manufacturing and Technology.
Water Testing Labs in Chennai
Application of rapid methods for the risk assessment of pharmaceutical processes Tim Sandle, Ph.D.
LAL: Choice of Test Method
Delivering value from MES: Optimizing Manufacturing Efficiency
Lesson 5: BRITE Seminar: GMP II
Microbiology Testing Labs in Chennai - TNTH
Astrix Technology Group
Quality System.
Lesson 8: BRITE Seminar: GMP II
II. 6 Quality risk management as part of…
QP FORUM 2018 QP DECISION MAKING.
Viadeis Value Selling: A Cloud Smart Sales App
Manufacture of Sterile Medicinal Products: Practical Examples
Manufacture of Sterile Medicinal Products: ‘Annex 1’ - DRAFT
PROCESS VALIDATION - ACTUAL REGULATION, PERFORMING AND INSPECTION
Presentation transcript:

R APID M ICRO M ETHODS PPAR 2013 Jeffrey W. Weber, PAT Project Manager Kalamazoo, MI Oct 2013

2 Rapid micro-biologic testing - Success stories: in-line TOC, etc.. Value, gaps, and roadblocks - RMM testing and continuous mfg Biologics II: RMM

3 Rapid Micro Methods are ~ 5 years behind PAT systems. J Weber – Opportunity to take lessons learned and apply to RMM arena. – Unfortunately consultants are reaping the benefits ($) Lack of guidance and understanding

4 “It should be noted that microbiology is a scientifically based discipline that deals with biological principles substantially different from those of analytical chemistry and engineering disciplines. Many times it is difficult for individuals without specific microbiological training to make the transition.” USP

5 PPAR Survey

6 what is the biggest gap for RMM systems? Staffing Environmental Monitoring

7 Current Micro Lab Testing

8 Manufacturing (PAT) In-plant testing Raw materials screening Process decisions EMA / EP support QC (Micro Labs) Lean labs More automation Less “micro” training USP / FDA aligned Who owns RMMs? RMM Is this an opportunity to align micro with PAT and engineering?

9 Discrete point sampling – EM – Raw Materials – Personnel – Sterility testing Limited temporal information Retrospective – “all or nothing” – Silos Current Micro Testing Product People Process / Plant Raw Materials Patient

10 Patient Raw Materials Continuous monitoring Holistic control Raw material characterization is part of process Extreme temporal information Infinite sublots Real Time Release Testing (parametric release) Future Micro Testing Product People Process / Plant Intelligence-based Manufacturing (IbM)

11 Patient Raw Materials Future RMM Platforms Product People Intelligence-based Manufacturing (IbM) Process / Plant Automated plate reader Aerosol cytometry Liquid Bioburden Automated Water Testing Online Water BioBurden Enhanced LIMS / SPC / Cpk - MVDA Personnel Automated Sampler Enhanced COA data

12 Online Total Organic Carbon for Water – Minimal regulatory impact to online testing – Improved process control over grab samples No guidance from USP, EP or JP initially for use of online testing – ASTM guidance E Companies have moved to RTRt water release – Business benefit Model Implementations

13 Successful Platforms Technology: Chromogenic Limulus amoebocyte lysate, or LAL assay. USP and EP Method D. A simplified and rapid endotoxin testing method. Recommended Applications Compendial endotoxin testing Development studies In-process testing System Roles Water testing (routine and post-maintenance) Buffer hold times Cleaning verification Endotoxin removal efficiency Final Product testing

14 RMM systems are orthogonal to compendial testing Different units – CFU versus BioCounts How to react to new information? – Regulatory requirement (i.e. heavy metals) – Product Quality Interaction with Regulatory Agencies RMM Challenges

15 Pfizer would like to see the development – Online Water Testing At-line bioburden – BioBurden Testing Simplified testing – Online Endotoxin – Environmental Monitoring Industry Perspectives

16 Questions?

17 Traditional Micro Challenges 10 6 Microorganisms 10 3 CulturableMicroorganisms 1SamplingLimitations Classic culture assay is less than perfect! 1 gram sample or 100 mL water Limitation of Growth Media Risk Analysis